MTOR and neoplasm: For instance, ADs weaken CSC properties by inhibiting the AKT/mTOR signaling axis [20], restore apoptosis sensitivity through modulation of the Bcl-2/Bax balance [22,23], and alleviate tumor-induced immunosuppression by blocking STAT3 signaling [23,24].